Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Barroeta

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 18, 2025
Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiersIsabel Barroeta, Laura Videla, María Carmona-Iragui, et al.
The Lancet. Neurology|August 16, 2025
Down syndrome and Alzheimer's disease: insights into biomarkers, clinical symptoms, and pathologyMichael S Rafii, Zinayida Schlachetzki, Isabel Barroeta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2025
Cargo of small extracellular vesicles from neuronal origin shows progression of dementia in individuals with Down syndromeAurélie Ledreux, Maria Carmona-Iragui, Laura Videla, et al.
Biomedicines|June 24, 2022
DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome PatientsManon Moreau, Maria Carmona-Iragui, Miren Altuna, et al.
Scientific Reports|June 2, 2017
Mutation Spectrum in the CACNA1A Gene in 49 Patients with Episodic AtaxiaCèlia Sintas, Oriel Carreño, Noèlia Fernàndez-Castillo, et al.
Alzheimer'S Research & Therapy|July 27, 2024
Correction: Diagnostic performance of plasma pTau<sub>217</sub>, pTau<sub>181</sub>, Aβ<sub>1‑42</sub> and Aβ<sub>1‑40</sub> in the LUMIPULSE automated platform for the detection of Alzheimer diseaseJavier Arranz, Nuole Zhu, Sara Rubio-Guerra, et al.
Alzheimer'S Research & Therapy|June 26, 2024
Diagnostic performance of plasma pTau<sub>217</sub>, pTau<sub>181</sub>, Aβ<sub>1-42</sub> and Aβ<sub>1-40</sub> in the LUMIPULSE automated platform for the detection of Alzheimer diseaseJavier Arranz, Nuole Zhu, Sara Rubio-Guerra, et al.
Research Square|January 3, 2024
Diagnostic performance of plasma pTau 217, pTau 181, Aβ 1-42 and Aβ 1-40 in the LUMIPULSE automated platform for the detection of Alzheimer diseaseJavier Arranz, Nuole Zhu, Sara Rubio-Guerra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersLucía Maure-Blesa, Maria Borrell Pichot, Íñigo Rodríguez-Baz, et al.
Frontiers in Neuroscience|April 18, 2022
Feasibility and Long-Term Compliance to Continuous Positive Airway Pressure Treatment in Adults With Down Syndrome, a Genetic Form of Alzheimer's DiseaseSandra Giménez, Ariadna Farre, Fátima Morente, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 18, 2025
Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiersIsabel Barroeta, Laura Videla, María Carmona-Iragui, et al.
The Lancet. Neurology|August 16, 2025
Down syndrome and Alzheimer's disease: insights into biomarkers, clinical symptoms, and pathologyMichael S Rafii, Zinayida Schlachetzki, Isabel Barroeta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2025
Cargo of small extracellular vesicles from neuronal origin shows progression of dementia in individuals with Down syndromeAurélie Ledreux, Maria Carmona-Iragui, Laura Videla, et al.
Biomedicines|June 24, 2022
DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome PatientsManon Moreau, Maria Carmona-Iragui, Miren Altuna, et al.
Scientific Reports|June 2, 2017
Mutation Spectrum in the CACNA1A Gene in 49 Patients with Episodic AtaxiaCèlia Sintas, Oriel Carreño, Noèlia Fernàndez-Castillo, et al.
Alzheimer'S Research & Therapy|July 27, 2024
Correction: Diagnostic performance of plasma pTau<sub>217</sub>, pTau<sub>181</sub>, Aβ<sub>1‑42</sub> and Aβ<sub>1‑40</sub> in the LUMIPULSE automated platform for the detection of Alzheimer diseaseJavier Arranz, Nuole Zhu, Sara Rubio-Guerra, et al.
Alzheimer'S Research & Therapy|June 26, 2024
Diagnostic performance of plasma pTau<sub>217</sub>, pTau<sub>181</sub>, Aβ<sub>1-42</sub> and Aβ<sub>1-40</sub> in the LUMIPULSE automated platform for the detection of Alzheimer diseaseJavier Arranz, Nuole Zhu, Sara Rubio-Guerra, et al.
Research Square|January 3, 2024
Diagnostic performance of plasma pTau 217, pTau 181, Aβ 1-42 and Aβ 1-40 in the LUMIPULSE automated platform for the detection of Alzheimer diseaseJavier Arranz, Nuole Zhu, Sara Rubio-Guerra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersLucía Maure-Blesa, Maria Borrell Pichot, Íñigo Rodríguez-Baz, et al.
Frontiers in Neuroscience|April 18, 2022
Feasibility and Long-Term Compliance to Continuous Positive Airway Pressure Treatment in Adults With Down Syndrome, a Genetic Form of Alzheimer's DiseaseSandra Giménez, Ariadna Farre, Fátima Morente, et al.
Pageof 8